Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding CollPlant Biotechnologies Ltd changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CLGN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1521+6
Shares1.96M1.80M−157.4K (−8.0%)
Value$33.1M$29.5M−$3.62M (−10.9%)

New holders (10)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CLGN in Q4 2021
InstitutionSharesValue% of portfolio
Zurcher Kantonalbank (Zurich Cantonalbank)24,623$403.0K0.00%
Kingsview Wealth Management, LLC18,415$301.0K0.01%
LPL Financial LLC14,770$242.0K0.00%
HRT Financial LP13,531$221.0K0.00%
Susquehanna International Group, LLP10,578$173.0K0.00%
UBS Group AG5,266$86.0K0.00%
The PNC Financial Services Group, Inc.3,600$58.0K0.00%
Simplex Trading, LLC1,606$26.0K0.00%
Advisor Group Holdings, Inc.248$4.00K0.00%
First Manhattan Co100$1.00K0.00%

Sold out (4)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CLGN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
State Street Corp182,266$3.08M
Renaissance Technologies LLC10,001$169.0K
ACT Capital Management, LLC7,500$127.0K
Tower Research Capital LLC (TRC)86$1.00K